Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.36ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.36ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.36EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.108EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.108EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.108ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.108ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.108EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.108EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.108ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.108ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JS.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JS.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JS.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JS.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JS.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.104EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.104EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.104ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.104ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.104EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.104EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.104ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.104ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HH.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HH.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HH.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HH.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.7.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.7.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used